Lilly director Alvarez receives small stock award

ELI LILLY & Co director Ralph Alvarez reported a compensation-related stock award, increasing his direct holdings.

Rhea-AI Filing Summary

ELI LILLY & Co director Ralph Alvarez reported a compensation-related stock award, increasing his direct holdings. On June 15, 2026, he acquired 10.9945 shares of common stock at $1,129.35 per share, characterized as a grant or award rather than an open-market purchase.

According to the footnotes, these shares were deferred as stock units under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in common stock after he leaves the board. Following this award, Alvarez directly holds 55,723.4672 shares of common stock and indirectly holds 758 shares through a trust, where he disclaims beneficial ownership beyond his pecuniary interest.

Insider Trade Summary

Grant/Award: 10.9945 shares

Grant/Award 2 txns

Insider Alvarez Ralph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10.9945	$1,129.35	$12K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 55,723.4672 shares (Direct); Common Stock — 758 shares (Indirect, By Trust)

Footnotes (2)

1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
2. F2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Key Figures

Stock award size: 10.9945 shares Award reference price: $1,129.35/share Direct holdings after award: 55,723.4672 shares +1 more

4 metrics

Stock award size 10.9945 shares Common stock grant/award on June 15, 2026

Award reference price $1,129.35/share Price per share for the 10.9945-share award

Direct holdings after award 55,723.4672 shares Common stock directly held by Ralph Alvarez after transaction

Indirect holdings via trust 758 shares Common stock held indirectly by trust associated with Alvarez

Key Terms

Lilly Directors' Deferral Plan, stock units, beneficial ownership, pecuniary interest

4 terms

Lilly Directors' Deferral Plan financial

"deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"

stock units financial

"deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

beneficial ownership regulatory

"The Reporting Person disclaims beneficial ownership of the reported securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ELI LILLY (LLY) director Ralph Alvarez report in this Form 4?

Ralph Alvarez reported receiving a small grant of ELI LILLY common stock as compensation. The award was deferred as stock units and will be settled in shares after he leaves board service, rather than being an open-market stock purchase.

How many ELI LILLY (LLY) shares did Ralph Alvarez acquire in the latest filing?

He acquired 10.9945 shares of ELI LILLY common stock. The filing classifies this as a grant or award tied to director compensation, not a market trade, and the units are deferred under a company deferral plan until he leaves the board.

What is Ralph Alvarez’s total ELI LILLY (LLY) share ownership after this transaction?

After the award, Alvarez directly holds 55,723.4672 ELI LILLY common shares. He also has an additional 758 shares held indirectly through a trust, for which he disclaims beneficial ownership except for any pecuniary interest described.

Was Ralph Alvarez’s ELI LILLY (LLY) transaction a market buy or sell?

The transaction was not a market buy or sell. It is labeled as a grant, award, or other acquisition, representing director compensation deferred into stock units rather than cash, with settlement in common shares after board service ends.

How are the new ELI LILLY (LLY) stock units for Ralph Alvarez treated under the deferral plan?

The newly awarded shares are deferred as stock units under the Lilly Directors' Deferral Plan. Instead of cash, compensation is converted into stock units, which will be settled in actual ELI LILLY common shares after Alvarez separates from board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alvarez Ralph

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		A		10.9945(1)	A	$1,129.35	55,723.4672	D
Common Stock								758	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Jonathan Groff for Ralph Alvarez, pursuant to authorization on file	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)